-Blockers and Plasma Renin Activity in Hypertension
- 12 January 1974
- Vol. 1 (5897), 60-62
- https://doi.org/10.1136/bmj.1.5897.60
Abstract
Long-term treatment with propranolol was shown to produce a sustained suppression of the renin-aldosterone system in hypertensive patients, despite concurrent diuretic treatment. However, the antihypertensive effect of this treatment correlated poorly with its effects on plasma renin activity and urinary aldosterone excretion. When prindolol, another β-adrenergic blocking drug, was substituted for propranolol, blood pressure control was retained, but there was a prompt rise in plasma renin activity, which was not attributable to changes in electrolyte balance. These observations suggest that the antihypertensive action of propranolol and other β-blockers does not result from their effects on plasma renin activity.Keywords
This publication has 9 references indexed in Scilit:
- High Catecholamine Essential Hypertension: Clinical and Physiological CharacteristicsAustralian and New Zealand Journal of Medicine, 1973
- EFFECT OF ALPRENOLOL ON BLOOD PRESSURE AND PLASMA RENIN ACTIVITY IN HYPERTENSIVE PATIENTSActa Medica Scandinavica, 1973
- Propranolol Inhibition of Renin SecretionNew England Journal of Medicine, 1972
- THE USE OF PRINDOLOL (VISKEN) IN THE TREATMENT OF HYPERTENSIONThe Medical Journal of Australia, 1972
- The Effect of Chronic Adrenergic Receptor Blockade on Plasma Renin Activity in ManJournal of Clinical Endocrinology & Metabolism, 1972
- Application of a Radioimmunoassay for Angiotensin I to the Physiologic Measurements of Plasma Renin Activity in Normal Human Subjects1Journal of Clinical Endocrinology & Metabolism, 1969
- Preliminary investigations of a new beta‐adrenoceptive receptor blocking drug, LB46, in manBritish Journal of Pharmacology, 1969
- Control of renin release in experimental hypertension.1969
- Measurement of Aldosterone in Peripheral Blood of Man and Sheep1Journal of Clinical Endocrinology & Metabolism, 1967